NCT03979534 Protecting Kidneys Through a Low Protein Diet: A Stepwise Multiple-Choice System Approach
| NCT ID | NCT03979534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier le Mans |
| Condition | Chronic Kidney Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-04-01 |
| Primary Completion | 2028-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2019-04-01 with a primary completion date of 2028-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Nephrology care continues to progress and recommendations are now focused on delaying as much as possible the need for renal replacement therapy ("intent-to-defer"strategy). Protein restriction is a valuable tool for stabilizing chronic kidney disease (CKD) and retarding the need for renal replacement therapy, but the best diet to be prescribed is still matter of discussion. This study is aimed at identifying implementation strategies for nutritional management of advanced CKD.
Eligibility Criteria
Inclusion Criteria: * All adult patients followed on the unit for advanced CKD, with Kidney disease stage 4-5 or stage 3 with fast progression and without contraindications. Exclusion Criteria: * Malnutrition or short life-expectancy * Patients aged less than 18 years old * Pregnant women, * Incapacity to complete the free-consent form, * Pateints refusing participation in the study, * Patients without healthcare coverage.
Contact & Investigator
Giorgina Piccoli, MD
PRINCIPAL INVESTIGATOR
Centre Hospitalier le Mans
Frequently Asked Questions
Who can join the NCT03979534 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03979534 currently recruiting?
Yes, NCT03979534 is actively recruiting participants. Contact the research team at cjadeau@ch-lemans.fr for enrollment information.
Where is the NCT03979534 trial being conducted?
This trial is being conducted at La Flèche, France, Le Mans, France.
Who is sponsoring the NCT03979534 clinical trial?
NCT03979534 is sponsored by Centre Hospitalier le Mans. The principal investigator is Giorgina Piccoli, MD at Centre Hospitalier le Mans. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.